Home
HelpTest Code MDSDF Myelodysplastic Syndrome (MDS), Diagnostic FISH, Varies
Ordering Guidance
Chromosome analysis is recommended as first-tier testing; order either CHRBM / Chromosome Analysis, Hematologic Disorders, Bone Marrow, or CHRHB / Chromosome Analysis, Hematologic Disorders, Blood. This second-tier test should only be ordered if chromosome analysis is not successful, as it does not increase the sensitivity for detection of myelodysplastic syndrome (MDS) for classic abnormalities (ie, -5/5q-, -7/7q-). If this test is ordered concurrently with a chromosomal study (CHRBM or CHRHB), testing will be held pending the results of the chromosome test. If the chromosome results are complete and informative, this test will be canceled. If the chromosome results are complete and normal, this test will be canceled. If a complete chromosome study is not achieved (<20 metaphases), this test will proceed. If an ambiguous abnormality (may include nonclonal abnormality or unresolved structural abnormality) is observed and targeted MDS probes could be useful in characterizing the abnormality, this test will be canceled and reordered with appropriate probes as MDSMF / Myelodysplastic Syndrome (MDS), Specified FISH, Varies.
This test should not be used to screen for residual MDS. If the patient is being treated for known abnormalities, MDSMF / Myelodysplastic Syndrome (MDS), Specified FISH, Varies is the more appropriate test order.
If targeted MDS fluorescence in situ hybridization (FISH) probes are preferred, order MDSMF / Myelodysplastic Syndrome (MDS), Specified FISH and request specific probes for targeted abnormalities.
This test is intended for instances when the entire MDS FISH panel is needed as a second-tier test. If limited MDS FISH probes are preferred, order MDSMF.
If this test is ordered in conjunction with AMLFA / Adult Acute Myeloid Leukemia Panel, FISH, Varies or AMLFP / Pediatric Acute Myeloid Leukemia Panel, FISH, Varies, it will be canceled and reordered as MDSMF to avoid duplicate FISH probe testing.
Shipping Instructions
Advise Express Mail or equivalent if not on courier service.
Necessary Information
1. A reason for testing must be provided. If this information is not provided, an appropriate indication for testing may be entered by Mayo Clinic Laboratories.
2. A flow cytometry and/or a bone marrow pathology report should be submitted with each specimen. The laboratory will not reject testing if this information is not provided, but appropriate testing and interpretation may be compromised or delayed.
Specimen Required
Submit only 1 of the following specimens:
Preferred
Specimen Type: Bone marrow
Container/Tube:
Preferred: Yellow top (ACD)
Acceptable: Green top (sodium heparin) or lavender top (EDTA)
Specimen Volume: 2 to 3 mL
Collection Instructions:
1. It is preferable to send the first aspirate from the bone marrow collection.
2. Invert several times to mix bone marrow.
3. Send bone marrow in original tube. Do not aliquot.
Acceptable
Specimen Type: Whole blood
Container/Tube:
Preferred: Yellow top (ACD)
Acceptable: Green top (sodium heparin) or lavender top (EDTA)
Specimen Volume: 6 mL
Collection Instructions:
1. Invert several times to mix blood.
2. Send whole blood in original tube. Do not aliquot.
Useful For
Detecting recurrent common chromosome abnormalities associated with myelodysplastic syndromes or other myeloid malignancies using a panel
As an adjunct to conventional chromosome studies in patients with MDS
Evaluating specimens in which chromosome studies are unsuccessful
Identifying and tracking known chromosome abnormalities in patients with MDS and monitoring response to therapy
Testing Algorithm
This test includes a charge for the probe application, analysis, and professional interpretation of results for 6 probe sets (12 individual fluorescence in situ hybridization [FISH] probes). Additional charges will be incurred for all reflex or additional probe sets performed. Analysis charges will be incurred based on the number of cells analyzed per probe set. If no cells are available for analysis, no analysis charges will be incurred.
This test is performed as panel testing only using the following analysis algorithm.
The panel includes testing for the following abnormalities using the probes listed:
inv(3) or t(3;3) or GATA2::MECOM fusion, GATA2/MECOM probe set
-5/5q-, D5S630/EGR1 probe set
-7/7q-, D7Z1/D7S486
+8, D8Z2/MYC probe set
-17/17p-, TP53/D17Z1 probe set
-20/20q-, D20S108/20qter probe set
Appropriate ancillary probes may be performed at consultant discretion to render comprehensive assessment. Any additional probes used will have the results included within the final report and will be performed at an additional charge. In the following situations, additional (reflex) testing may be performed at the laboratory's discretion and may be influenced by available karyotype results or other FISH testing.
In the absence of GATA2::MECOM fusion, when an extra GATA2 signal is identified, testing using the PRDM16/GATA2 probe set may be performed to identify a potential t(1;3)(p36;q21).
In the absence of GATA2::MECOM fusion, when an extra MECOM signal is identified, testing using the break-apart MECOM probe set may be performed to identify a potential variant translocation involving MECOM, t(3;var)(q26.2;?).
Method Name
Fluorescence In Situ Hybridization (FISH)
Reporting Name
MDS, Diagnostic FISHSpecimen Type
VariesSpecimen Minimum Volume
Bone marrow: 1 mL; Whole blood: 2 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Varies | Ambient (preferred) | |
| Refrigerated | ||
Reject Due To
All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.Reference Values
An interpretive report will be provided.
Day(s) Performed
Monday through Friday
Report Available
7 to 10 daysPerforming Laboratory
Mayo Clinic Laboratories in Rochester
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
88271 x 12, 88275 x 6, 88291-FISH Probe, Analysis, Interpretation; 6 probe sets
88271 x 2, 88275-FISH Probe, Analysis; each additional probe set (if appropriate)
LOINC Code Information
| Test ID | Test Order Name | Order LOINC Value |
|---|---|---|
| MDSDF | MDS, Diagnostic FISH | 62367-8 |
| Result ID | Test Result Name | Result LOINC Value |
|---|---|---|
| 614278 | Result Summary | 50397-9 |
| 614279 | Interpretation | 69965-2 |
| 614280 | Result Table | 93356-4 |
| 614281 | Result | 62356-1 |
| GC121 | Reason for Referral | 42349-1 |
| GC122 | Specimen | 31208-2 |
| 614282 | Source | 31208-2 |
| 614283 | Method | 85069-3 |
| 614284 | Additional Information | 48767-8 |
| 614285 | Disclaimer | 62364-5 |
| 614286 | Released By | 18771-6 |
Forms
If not ordering electronically, complete, print, and send an Hematopathology/Cytogenetics Test Request (T726) with the specimen.